The IJTLD
The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.
We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
Public Health Action
Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.
We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable Development Goals (SDGs).
IJTLD Open
Launched in January 2024, IJTLD Open is The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD.
We welcome submissions on the development of diagnostics and treatments for the prevention, management and control of respiratory diseases.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Severe COVID-19 cases with a history of active or latent tuberculosis
In a letter to the editors, authors report on symptom development, disease progression and treatment for three cases, each representing a different TB scenario.
Rapid development of a novel portable negative pressure device
A portable, negative pressure environment is one means of confronting these challenges, and could offer benefits to patients, healthcare workers, and institutions alike.
Rapid development of a portable negative pressure procedural tent
A new tent system has been designed to provide healthcare workers separation and protection from exhaled droplets and aerosols, while allowing contact and support for procedures.
COVID-19 in Africa: preparing for the storm
In response to COVD-19, Africa should develop robust collaborative research programmes, funded by African governments and partners, to include epidemiological, health system, implementation, clinical trials, immunological and virological research.
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed
Letter highlighting that responsible stewardship of the bacille Calmette-Guérin (BCG) vaccine in the context of the COVID-19 epidemic is urgently needed.
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City
To ensure that scientific research of immediate concern is shared as rapidly as possible, The Union is fast-tracking accepted articles…